Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

At baseline (week 0), these groups were similar (p > 0.20) in terms of age, female to male sex ratio (0.62 vs. 0.58), latitude of residency, enrollment seasons, randomization to vitamin D supplementation (49.5 vs. 52.3%), exposure to EFV (45.5 vs. 37.6%), and CD4+ T-cell (CD4) count (505 ± 149 vs. 550 ± 224 cells/μl of blood).

Source: CHARACTERISTICS OF STUDY POPULATION BY RACE. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Double-blind reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

YLH (18 to 25 years old) represented two self-identified racial groups (African: American (AAs) and others) participating in a randomized, double-blind, placebo-controlled, multicenter trial () within the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN; , ).

Source: Methods.

All participants were treated with ≥3 antiretrovirals (ARVs) for ≥90 days and with plasma HIV-1 RNA (viral load) <5,000 copies/mL within 60 days.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein

Study design awaiting verification · Frontiers in Genetics · 2013

Original publication title

Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein

Travis R. Porter; Xuelin Li; Charles B. Stephensen; Kathleen Mulligan; Brandy Rutledge; Patricia M. Flynn; Jorge Lujan-Zilbermann; Rohan Hazra; Craig M. Wilson; Peter L. Havens; Jianming Tang; Adolescent MedicineTrials Network for HIV/AIDS Interventions (ATN) 063 study team

Copyright © 2013 Porter, Li, Stephensen, Mulligan, Rutledge, Flynn, Lujan-Zilbermann, Hazra, Wilson, Havens, Tang and for the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 063 study team.

Original publication · Publisher record · CC BY 3.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Serum 25-hydroxyvitamin D [25(OH)D] is often deficient (<12 ng/ml) or insufficient (<20 ng/ml) in youth living with human immunodeficiency virus type 1 infection (YLH). Based on evidence from multiple genome-wide association studies, we hypothesized that genetic factors associated with 25(OH)D deficiency should be readily detectable in YLH even when controlling for other known factors, including use of the antiretroviral drug efavirenz (EFV). Genotyping by bi-directional sequencing targeted 15 single nucleotide polymorphisms (SNPs) at the GC/DBP locus, with a focus on coding and regulatory variants, as well as those repeatedly reported in the literature.

Three intronic SNPs (rs222016, rs222020, and rs222029) in a conserved haplotype block had unequivocal association signals (false discovery rate ≤ 0.006). In particular, the minor allele G for rs222020 was highly unfavorable among 192 YLH (99 African: Americans and 93 others), as gauged by relatively low likelihood for 25(OH)D sufficiency at enrollment (odds ratio = 0.31, p = 9.0 × 10-4). In a reduced multivariable model, race, season, latitude, body mass index, exposure to EFV, and rs222020-G were independent factors that collectively accounted for 38% of variance in the log10-transformed 25(OH)D concentration (p < 0.0001).

Interaction terms were evident for rs222020-G × season (p < 0.001), latitude × season (especially fall and winter; p < 0.01), and race × EFV use (p = 0.024). Overall, variance in serum 25(OH)D is substantially attributable to multiple factors, but the exact contribution of genetic and non-genetic factors can be obscured by partial overlaps and frequent interactions.

Authors’ abstract

Serum 25-hydroxyvitamin D [25(OH)D] is often deficient (<12 ng/ml) or insufficient (<20 ng/ml) in youth living with human immunodeficiency virus type 1 infection (YLH). Based on evidence from multiple genome-wide association studies, we hypothesized that genetic factors associated with 25(OH)D deficiency should be readily detectable in YLH even when controlling for other known factors, including use of the antiretroviral drug efavirenz (EFV). Genotyping by bi-directional sequencing targeted 15 single nucleotide polymorphisms (SNPs) at the GC/DBP locus, with a focus on coding and regulatory variants, as well as those repeatedly reported in the literature.

Three intronic SNPs (rs222016, rs222020, and rs222029) in a conserved haplotype block had unequivocal association signals (false discovery rate ≤ 0.006). In particular, the minor allele G for rs222020 was highly unfavorable among 192 YLH (99 African: Americans and 93 others), as gauged by relatively low likelihood for 25(OH)D sufficiency at enrollment (odds ratio = 0.31, p = 9.0 × 10-4). In a reduced multivariable model, race, season, latitude, body mass index, exposure to EFV, and rs222020-G were independent factors that collectively accounted for 38% of variance in the log10-transformed 25(OH)D concentration (p < 0.0001).

Interaction terms were evident for rs222020-G × season (p < 0.001), latitude × season (especially fall and winter; p < 0.01), and race × EFV use (p = 0.024). Overall, variance in serum 25(OH)D is substantially attributable to multiple factors, but the exact contribution of genetic and non-genetic factors can be obscured by partial overlaps and frequent interactions.

Publication and source details

Original title: Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein

Travis R. Porter; Xuelin Li; Charles B. Stephensen; Kathleen Mulligan; Brandy Rutledge; Patricia M. Flynn; Jorge Lujan-Zilbermann; Rohan Hazra; Craig M. Wilson; Peter L. Havens; Jianming Tang; Adolescent MedicineTrials Network for HIV/AIDS Interventions (ATN) 063 study team

Frontiers in Genetics · 2013

Edited by: José A. G. Agúndez, University of Extremadura, Spain

Reviewed by: Diego Maria Michele Fornasari, University of Milan, Italy; Mehmet Tevfik Dorak, Florida International University, USA

*Correspondence: Jianming Tang, Department of Medicine, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL 35294, USA e-mail: jtang@uab.edu

This article was submitted to Pharmacogenetics and Pharmacogenomics, a section of the journal Frontiers in Genetics.

Copyright © 2013 Porter, Li, Stephensen, Mulligan, Rutledge, Flynn, Lujan-Zilbermann, Hazra, Wilson, Havens, Tang and for the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 063 study team.2013https://creativecommons.org/licenses/by/3.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T12:26:26.178139+00:00

DOI: 10.3389/fgene.2013.00234 · PMC3827582